These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Results of therapy with radioactive suspensions in peritoneal and pleural neoplastic dissemination]. Sobral JM; Clode WH; Baptista AM Arq Patol; 1966 Aug; 38(1):17-24. PubMed ID: 5998980 [No Abstract] [Full Text] [Related]
3. [Possibilities of radioactive gold therapy in peritoneal carcinosis and as supplementary treatment in gastric and intestinal carcinoma]. Altenbrunn HJ; Georgi P; Andrysek O; Steenbeck L; Ernst H; Gibel W; Wildner GP Radiobiol Radiother (Berl); 1966; 7(2):157-64. PubMed ID: 5957096 [No Abstract] [Full Text] [Related]
4. [10-year record of treatment of metastaticascites with gold-198]. Reboul J; Delorme G; Bellet M; Tessier JP; Caillé JM; Grelet P; Lachaise A J Radiol Electrol Med Nucl; 1969 May; 50(5):328-30. PubMed ID: 5401318 [No Abstract] [Full Text] [Related]
5. [Radiotherapy in the complex treatment of malignant tumors of the ovaries]. Mitrov GG; Mlychkov KhN; Khristov IN Med Radiol (Mosk); 1968 Jan; 13(1):3-8. PubMed ID: 5742265 [No Abstract] [Full Text] [Related]
6. [Radioactive gold treatment of effusions caused by neoplasms]. Rotte K; Feltmann K Med Klin; 1969 Sep; 64(36):1598-603. PubMed ID: 4310135 [No Abstract] [Full Text] [Related]
7. [Intracellular radiogold storage in the electron microscopic picture]. Choné B Strahlentherapie; 1965 Jul; 127(3):430-8. PubMed ID: 4158488 [No Abstract] [Full Text] [Related]
8. [Treatment of ascites. Goal is symptom remission and not cure of ascites]. Schölmerich J MMW Fortschr Med; 1999 Dec; 141(49-50):45-6. PubMed ID: 10726147 [No Abstract] [Full Text] [Related]
11. [Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report]. Graziosi L; Bugiantella W; Cavazzoni E; Donini A G Chir; 2009 May; 30(5):237-9. PubMed ID: 19505418 [TBL] [Abstract][Full Text] [Related]
12. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844 [TBL] [Abstract][Full Text] [Related]
13. [Recurrent ascites in peritoneal mesothelioma. Its diagnostic and therapeutic management]. Romero Arauzo MJ; Taxonera Samsó C; Ciriza de los Ríos C; Díez Ordoñez MZ; Díaz-Rubio M; Lopez Asenjo JA Rev Esp Enferm Dig; 1995 Mar; 87(3):263-6. PubMed ID: 7742058 [TBL] [Abstract][Full Text] [Related]
14. [Effects of combined treatment using ionising rays and cyclophosphamide on the mitotic rate of Ehrlich ascites tumors]. Kaufmann H; Harder S Strahlentherapie; 1971 Dec; 142(6):677-80. PubMed ID: 5153125 [No Abstract] [Full Text] [Related]
15. Management of effusions. Silverberg I Oncology; 1970; 24(1):26-30. PubMed ID: 4984638 [No Abstract] [Full Text] [Related]
16. Clarification on 'shunting malignant ascites'. Klopp A Am J Nurs; 1984 Oct; 84(10):1208. PubMed ID: 6567446 [No Abstract] [Full Text] [Related]
17. Shunting malignant ascites. Klopp A Am J Nurs; 1984 Feb; 84(2):212-3. PubMed ID: 6559539 [No Abstract] [Full Text] [Related]
18. [Therapy of ovarian cancer without ascites, using radioactivesuspensions; Study of results analyzed by computer]. Clode WH; Rodrigues E; Nogueira AR; Baptista AM Arq Patol; 1974 Apr; 46(1):89-96. PubMed ID: 4462525 [No Abstract] [Full Text] [Related]
19. Treatment of malignant ascites. Chung M; Kozuch P Curr Treat Options Oncol; 2008 Jun; 9(2-3):215-33. PubMed ID: 18777213 [TBL] [Abstract][Full Text] [Related]
20. Current and future options in the treatment of malignant ascites in ovarian cancer. Woopen H; Sehouli J Anticancer Res; 2009 Aug; 29(8):3353-9. PubMed ID: 19661355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]